Relmada Therapeutics, Inc. (RLMD)

3.99 +0.18 (+4.72%) USD  |  NASDAQ  |  Jan 22, 10:23
More

Relmada Therapeutics EPS Basic from Tax Loss Carryforward (Quarterly)

EPS Basic from Tax Loss Carryforward (Quarterly) Chart

View EPS Basic from Tax Loss Carryforward (Quarterly) for RLMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Basic from Tax Loss Carryforward (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Basic from Tax Loss Carryforward (Quarterly) Range, Past 5 Years

View EPS Basic from Tax Loss Carryforward (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Basic from Tax Loss Carryforward (Quarterly) Benchmarks

View EPS Basic from Tax Loss Carryforward (Quarterly) Benchmarks
Start Trial
Amicus Therapeutics, Inc. --
Invivyd, Inc. --
Arcellx, Inc. --
Puma Biotechnology, Inc. --
NovaBay Pharmaceuticals, Inc. --